PCM Reading Tools
How to cite item
Significance of alectinib in anaplastic lymphoma kinase-tyrosine kinase inhibitors for anaplastic lymphoma kinase-positive patients with non–small cell lung cancer
Citation Format
ABNT
APA
BibTeX
CBE
EndNote - EndNote format (Macintosh & Windows)
MLA
ProCite - RIS format (Macintosh & Windows)
RefWorks
Reference Manager - RIS format (Windows only)
Turabian
@article{{PCM}{5254}, author = {Chikaishi, Y., Kobayashi, K., Matsumiya, H., Taira, A., Nabe, Y., Shinohara, S., Kuwata, T., Takenaka, M., Oka, S., Hirai, A., Kuroda, K., Imanishi, N., Ichiki, Y., Tanaka, F.}, title = {Significance of alectinib in anaplastic lymphoma kinase-tyrosine kinase inhibitors for anaplastic lymphoma kinase-positive patients with non–small cell lung cancer}, journal = {Precision Cancer Medicine}, volume = {3}, number = {0}, year = {2020}, url = {https://pcm.amegroups.org/article/view/5254} }